Mechanisms and Therapeutic Approaches of Gasdermin D-Induced Pyroptosis in Sepsis: Implications for Clinical Practice - Takeaways - MDSpire

Mechanisms and Therapeutic Approaches of Gasdermin D-Induced Pyroptosis in Sepsis: Implications for Clinical Practice

  • By

  • Zixia Wang

  • Xiangyang Li

  • Bo Yuan

  • Junqiang Zhang

  • April 21, 2026

  • 0 min

Share

  • 1

    Sepsis causes 11 million deaths annually, with significant geographic disparities and long-term cognitive impairments in survivors.

  • 2

    Gasdermin D (GSDMD) is a key mediator of pyroptosis, leading to cell lysis and multi-organ injury during sepsis.

  • 3

    GSDMD activation occurs through canonical and non-canonical pathways, both resulting in pore formation and inflammatory amplification.

  • 4

    Elevated pyroptosis markers correlate with organ failure in sepsis, indicating their potential as prognostic indicators.

  • 5

    Promising therapies targeting GSDMD include disulfiram and anti-GSDMD mAb26.5, though clinical translation faces significant challenges.

Original Source(s)

Mechanisms and Therapeutic Approaches of Gasdermin D-Induced Pyroptosis in Sepsis: Implications for Clinical Practice

  • by Zixia Wang, Xiangyang Li, Bo Yuan, Junqiang Zhang

  • April 21, 2026

Related Content

Polymyxin B-induced acute kidney injury in a burn patient: a case report and pharmaceutical care

Association of TyG index with sepsis incidence and mortality: a prospective study with diabetes stratification

Compliance of procalcitonin-guided antibiotic therapy in adult infectious patients in China: a multicenter real-world retrospective study